Imbio PHA (4.0.0) vs Us2.ai
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Imbio PHA processes CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation and aid in diagnosing pulmonary embolism and hypertension. In contrast, Us2.ai automates the analysis of echocardiograms for a broader range of cardiac conditions, including amyloidosis, heart failure, and aortic stenosis, in addition to pulmonary hypertension. While both are FDA-cleared AI tools for cardiac assessment, their distinct primary imaging modalities (CTPA vs. echocardiography) make them adjacent rather than direct competitors, serving different points in the diagnostic pathway.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Imbio PHA (4.0.0) is designed to analyze CT pulmonary angiogram (CTPA) scans to measure cardiac structures. In contrast, Us2.ai automates the analysis of echocardiograms.
Imbio PHA (4.0.0) focuses on assessing potential right ventricular dilation and aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by measuring right and left ventricle diameters, and main pulmonary artery and aorta diameters, then calculating RV/LV and PA/Ao ratios. Us2.ai automates echocardiogram analysis to detect cardiac conditions such as amyloidosis, heart failure, aortic stenosis, and pulmonary hypertension, providing comprehensive automated measurements including 2D, Doppler, M-mode, and strain analysis.
Imbio PHA (4.0.0) integrates with native DICOM tools and workflows, and its outputs can be automatically sent to PACS. Us2.ai offers integration with PACS, CVIS, EMR, and ultrasound devices, supporting DICOM and HL7, and is designed to fit into existing hospital infrastructure with minimal IT effort.
Imbio PHA (4.0.0) generates annotated DICOM images and provides summary reports in PDF format. Us2.ai produces fully automated, zero-click structured reports, offers editable AI outputs and annotations, and provides guideline-based reporting.
Imbio PHA (4.0.0) is designed to support Cardiology, Pulmonology, and Radiology. Us2.ai primarily serves Cardiology, Critical Care, and Emergency Medicine.